XERMELO® (telotristat ethyl) tablets, 250mg Home | For patients
XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy. You are encouraged to report negative side effects of prescription drugs to the FDA.
XERMELO® (telotristat ethyl) tablets, 250mg Home | For US …
Learn about XERMELO, a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea (CSD) in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
Patient Access and Support | XERMELO® (telotristat ethyl)
XERMELO is a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
Efficacy | XERMELO® (telotristat ethyl)
XERMELO is a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
Access and Support (telotristat ethyl) tablets, 250mg - XERMELO
XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy. You are encouraged to report negative side effects of prescription drugs to the FDA.
Safety & Side Effects | For patients - XERMELO
XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy. You are encouraged to report negative side effects of prescription drugs to the FDA.
About carcinoid syndrome diarrhea (CSD) - XERMELO
XERMELO is a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
Diet & Nutrition | For patients - XERMELO
XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy. You are encouraged to report negative side effects of prescription drugs to the FDA.
Resources | XERMELO® (telotristat ethyl)
XERMELO is a tryptophan hydroxylase inhibitor indicated for the treatment of carcinoid syndrome diarrhea in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
Is Your Current Treatment Enough | For patients - XERMELO
XERMELO is a prescription pill, used along with somatostatin analog (SSA) therapy, for carcinoid syndrome diarrhea in adults who are not adequately controlled by SSA therapy. You are encouraged to report negative side effects of prescription drugs to the FDA.